Calcium Fluoride Nanozyme for Ultrasound‐Amplified and Ca2+ Overload‐Enhanced Catalytic Tumor Nanotherapy

Caihong Dong,Xinyue Dai,Xi Wang,Qing Lu,Liang Chen,Xinran Song,Li Ding,Hui Huang,Wei Feng,Yu Chen,Meiqi Chang
DOI: https://doi.org/10.1002/adma.202205680
IF: 29.4
2022-09-16
Advanced Materials
Abstract:The anticancer mechanism of nanozyme is dominantly associated with generation capacity of reactive oxygen species (ROS) caused by the valence change of metal elements. However, very few researches have been focused and achieved on the exploration and development of enzyme‐mimicking activities of valence‐invariable metal compound. Herein, the distinct valence‐invariable calcium fluoride (CaF2) nanozyme with ultrasound (US)‐enhanced peroxidase (POD)‐mimicking activity is rationally designed and engineered for efficient calcium (Ca2+) overload‐enhanced catalytic tumor nanotherapy, which is the first paradigm of Ca‐based nanozymes for catalytic cancer treatment. The release of exogenous Ca2+ ions from CaF2 nanocrystals and deleterious ROS generation derived from US‐amplified POD‐mimicking properties facilitate intracellular Ca2+ accumulation and achieve Ca2+ overload‐induced mitochondrial dysfunction through introducing exogenous Ca2+ ions and regulating calcium‐pumping channels of neoplastic cells. Especially, US as exogenous energy input is capable of substantially amplifying POD‐mimicking catalytic activities of CaF2 nanozyme, ultimately achieving efficient antineoplastic outcome on both 4T1 breast tumor and H22 hepatic carcinoma animal models. Such a discovery of enzyme‐like activity of valence‐invariable metal compound can broaden the cognition scope of nanozymes and effectively serve the field of catalytic and chemoreactive nanomedicine. This article is protected by copyright. All rights reserved
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?